Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Doherty

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Current Oncology (Toronto, Ont.)|March 28, 2023
Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide AnalysisVivian S Tan, Michael C Tjong, Wing C Chan, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancerFabio Y Moraes, Alireza Mansouri, Archya Dasgupta, et al.
The Journal of Experimental Medicine|November 11, 2009
Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosisAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Journal of Thoracic Disease|September 11, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practiceChin Heng Fong, Nicholas Meti, Timothy Kruser, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
Clinical Lung Cancer|January 24, 2017
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to TherapyCatherine Labbé, Yvonne Leung, João Gabriel Silva Lemes, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2026
Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD)Grainne M O'Kane, Aruz Mesci, Raymond W Jang, et al.
Plos Neglected Tropical Diseases|June 26, 2008
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research prioritiesDiana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, et al.
Journal of Translational Medicine|February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samplesSinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Current Oncology (Toronto, Ont.)|March 28, 2023
Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide AnalysisVivian S Tan, Michael C Tjong, Wing C Chan, et al.
Clinical and Vaccine Immunology : CVI|February 10, 2006
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosisAbebech Demissie, Eliane M S Leyten, Markos Abebe, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2021
Impact of EGFR mutation on outcomes following SRS for brain metastases in non-small cell lung cancerFabio Y Moraes, Alireza Mansouri, Archya Dasgupta, et al.
The Journal of Experimental Medicine|November 11, 2009
Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosisAurelie Cobat, Caroline J Gallant, Leah Simkin, et al.
Journal of Thoracic Disease|September 11, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practiceChin Heng Fong, Nicholas Meti, Timothy Kruser, et al.
Advances in Radiation Oncology|June 13, 2020
Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain MetastasesMatthew Ramotar, Sierra Barnes, Fabio Moraes, et al.
Clinical Lung Cancer|January 24, 2017
Real-World EQ5D Health Utility Scores for Patients With Metastatic Lung Cancer by Molecular Alteration and Response to TherapyCatherine Labbé, Yvonne Leung, João Gabriel Silva Lemes, et al.
JHEP Reports : Innovation in Hepatology|January 26, 2026
Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD)Grainne M O'Kane, Aruz Mesci, Raymond W Jang, et al.
Plos Neglected Tropical Diseases|June 26, 2008
Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research prioritiesDiana Boraschi, Markos Abebe Alemayehu, Abraham Aseffa, et al.
Journal of Translational Medicine|February 24, 2020
Identification and clinical impact of potentially actionable somatic oncogenic mutations in solid tumor samplesSinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, et al.
Pageof 15